New study sheds light on the intermediary phases of endothelial-mesenchymal transition (EndoMT) in cancer cells (IMAGE)
Caption
Researchers develop a novel reporting system called the “EndoMT reporter endothelial cells” or EMRECs, to visualize the intermediate phases of EndoMT. Using RNA-sequencing and gene expression analyses in EMRECs, they identify CD40 as a novel partial EndoMT marker.
Credit
Dr. Kazuki Takahashi from Tokyo Medical and Dental University, Japan
Usage Restrictions
Cannot be reused without permission
License
Original content